Product logins

Find logins to all Clarivate products below.


Diabetes Care Devices | Market Insights | US | 2025

The US diabetes care device market will see strong growth over the forecast period, fueled by FDA approvals for new products with expanded indications—especially for the broader type 2 diabetes population—as well as the introduction of new technologies and innovative products in the diabetes care device space. Notably, the CGM device segment will witness rapid expansion, driven by increased Medicare coverage and over-the-counter approvals for the type 2 diabetes population, thereby enhancing patient access to these devices.

This Medtech 360 Report provides comprehensive data and analysis on the state of the diabetes care device market in the US from 2019 through 2033.

Related Medtech Insights Reports

Report
Diabetes Care Devices – Market Insights – Asia Pacific
The Asia Pacific diabetes care device market is expected to experience moderate growth over the forecast period, driven by a rising diabetes population, untapped market opportunities, regulatory…
Report
Diabetes Care Devices – Market Insights – United States
The US diabetes care device market will see strong growth over the forecast period, spurred by various factors, namely FDA approvals for new products with expanded indications, strong growth in…
Report
Heart Valve Devices | Market Insights | US | 2025
The US heart valve device market has seen rapid shifts in market dynamics, from renewed growth in the surgical heart valve device segment to the introduction of novel products and key approvals of…
Report
Spinal Implants | Market Insights | US | 2025
The US spinal implant market is projected to grow steadily, despite being limited by declining ASPs. This growth will be supported by favorable demographic trends, such as an aging population, and…
Report
Pain Management Devices – Market Insights – Europe
The European pain management space remains active, with manufacturers continuing to innovate and work toward receiving regulatory approval for new indications, supporting market growth in Europe…